Evidence map›Paper›PMID 25635047›Full record

ArticleThe Journal of biological chemistry2015

Prolyl-4-hydroxylase domain protein 2 controls NF-κB/p65 transactivation and enhances the catabolic effects of inflammatory cytokines on cells of the nucleus pulposus.

Jun Li, Wen Yuan, Shuai Jiang, Wei Ye, Hao Yang, Irving M Shapiro, Makarand V Risbud

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 49 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. PHD3 is a transcriptional coactivator of HIF-1α in nucleus pulposus cells independent of the PKM2-JMJD5 axis.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Jun LiFrom the Department of Orthopaedic Surgery and the Department of Orthopaedic Surgery, Changzheng Hospital, Second Military Medical University, Shanghai 200003, China.
Wen Yuanthe Department of Orthopaedic Surgery, Changzheng Hospital, Second Military Medical University, Shanghai 200003, China.
Shuai Jiangthe Department of Orthopaedic Surgery, Changzheng Hospital, Second Military Medical University, Shanghai 200003, China.
Wei YeFrom the Department of Orthopaedic Surgery and the Department of Orthopaedic Surgery, Sun Yat-sen Memorial Hospital of Sun Yat-Sen University, Guangzhou 510120, China, and.
Hao YangFrom the Department of Orthopaedic Surgery and the Department of Orthopaedics, First Affiliated Hospital of Sun Yat-Sen University, Guangzhou 510080, China.
Irving M ShapiroFrom the Department of Orthopaedic Surgery and the Graduate Program in Cell and Developmental Biology, Thomas Jefferson University, Philadelphia, Pennsylvania, 19107.
Makarand V RisbudFrom the Department of Orthopaedic Surgery and the Graduate Program in Cell and Developmental Biology, Thomas Jefferson University, Philadelphia, Pennsylvania, 19107, makarand.risbud@jefferson.edu.
Second Military Medical University · CNThomas Jefferson University · USSun Yat-sen University · CN

Funding

Role of HIF-1 in Intervertebral Disc FunctionR01AR055655 · NIAMS · THOMAS JEFFERSON UNIVERSITY · PI RISBUD, MAKARAND V · 2008 to 2023
$6.1M
Regeneration of Nucleus Pulposus by Tissue EngineeringR01AR050087 · NIAMS · THOMAS JEFFERSON UNIVERSITY · PI RISBUD, MAKARAND V, SHAPIRO, IRVING M · 2005 to 2013
$3.0M
Disruption of Osmoregulation Promotes Degenerative Disc DiseaseR01AR064733 · NIAMS · THOMAS JEFFERSON UNIVERSITY · PI RISBUD, MAKARAND V, SHAPIRO, IRVING M · 2014 to 2018
$2.4M
NIAMS NIH HHS AR050087NIAMS NIH HHS AR055655NIAMS NIH HHS AR064733NIAMS NIH HHS R01 AR050087NIAMS NIH HHS R01 AR055655NIAMS NIH HHS R01 AR064733
6 · The paper itself

Abstract

Prolyl-4-hydroxylase (PHD) proteins are key in sensing tissue hypoxia. In nucleus pulposus (NP) cells, our previous work demonstrated that PHD isoforms have a differential contribution in controlling hypoxia-inducible factor (HIF)-α degradation and activity. Recently we have shown that a regulatory relationship exists between PHD3 and inflammatory cytokines in NP cells. With respect to PHD2, the most abundant PHD isoform in NP cells, very little is known concerning its function and regulation under inflammatory conditions that characterize intervertebral disc degeneration. Here, we show that PHD2 is a potent regulator of the catabolic activities of TNF-α; silencing of PHD2 significantly decreased TNF-α-induced expression of catabolic markers including SDC4, MMP-3, MMP-13, and ADAMTS5, as well as several inflammatory cytokines and chemokines, while partially restoring aggrecan and collagen II expression. Use of NF-κB reporters with ShPHD2, SiHIF-1α, as well as p65(-/-), PHD2(-/-), and PHD3(-/-) cells, shows that PHD2 serves as a co-activator of NF-κB/p65 signaling in HIF-1-independent fashion. Immunoprecipitation of endogenous and exogenously expressed tagged proteins, as well as fluorescence microscopy, indicates that following TNF-α treatment, PHD2 interacts and co-localizes with p65. Conversely, loss of function experiments using lentivirally delivered Sh-p65, Sh-IKKβ, and NF-κB inhibitor confirmed that cytokine-dependent PHD2 expression in NP cells requires NF-κB signaling. These findings clearly demonstrate that PHD2 forms a regulatory circuit with TNF-α via NF-κB and thereby plays an important role in enhancing activity of this cytokine. We propose that during disc degeneration PHD2 may offer a therapeutic target to mitigate the deleterious actions of TNF-α, a key proinflammatory cytokine.

Indexed as

Transcriptional ActivationAnimalsCells, CulturedGene Expression RegulationGene SilencingHEK293 CellsHumansHypoxia-Inducible Factor-Proline DioxygenasesInterleukin-1betaIntervertebral DiscIntervertebral Disc DegenerationNF-kappa BProcollagen-Proline DioxygenaseRats, WistarSignal TransductionTranscription Factor RelAEgln1 protein, ratHypoxia-Inducible Factor-Proline DioxygenasesInterleukin-1betaNF-kappa BProcollagen-Proline DioxygenaseTranscription Factor RelATumor Necrosis Factor-alphaCytokine ActionHypoxia-inducible Factor (HIF)Intervertebral DiscNF-kappa B (NF-KB)Nucleus PulposusProlyl HydroxylaseTumor Necrosis Factor (TNF)

Identifiers

PMID25635047
PMCPMC4358139
OpenAlexW2043491040

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.